Draveli, France

Anne-Sophie Casagrande

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Draveil, FR (2014 - 2016)
  • Draveli, FR (2015 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anne-Sophie Casagrande

Introduction

Anne-Sophie Casagrande is a prominent inventor based in Draveli, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target phosphodiesterase 10 (PDE 10A). With a total of five patents to her name, her work has the potential to impact the treatment of various central nervous system diseases.

Latest Patents

Among her latest patents are the "Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)." This invention relates to compounds that are useful in treating conditions such as psychosis, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain, and ophthalmic diseases. Another notable patent is the "Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)," which shares similar applications and benefits.

Career Highlights

Throughout her career, Anne-Sophie has worked with notable companies such as Allergan, Inc. and Exonhit Therapeutics. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Anne-Sophie has collaborated with esteemed colleagues, including Bertrand Leblond and Thierry Taverne. These partnerships have fostered an environment of innovation and have led to the successful development of her patented compounds.

Conclusion

Anne-Sophie Casagrande's work exemplifies the impact of innovative thinking in the pharmaceutical field. Her contributions through her patents are paving the way for new treatments for various diseases, showcasing her dedication to improving healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…